pilocarpine has been researched along with boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gylfe, E; Sjödin, L; Viitanen, E | 1 |
| Akiyama, T; Hirohata, Y; Imoto, I; Okabayashi, Y; Otsuki, M | 1 |
2 other study(ies) available for pilocarpine and boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester
| Article | Year |
|---|---|
Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells.
Topics: Amylases; Animals; Binding, Competitive; Calcium; Carbachol; Cytoplasm; Dose-Response Relationship, Drug; Guinea Pigs; Islets of Langerhans; Male; Muscarinic Agonists; Pilocarpine; Sincalide | 1997 |
Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclase Inhibitors; Amylases; Animals; Bombesin; Carbachol; Cell Membrane; Cholecystokinin; Colforsin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Kinetics; Male; Pancreas; Pilocarpine; Rats; Rats, Wistar; Sincalide; Tetradecanoylphorbol Acetate; Vasoactive Intestinal Peptide | 1998 |